Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00256386 · ClinicalTrials.gov registry record · NA

LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring

A NA study, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
800
Enrollment target

NCT00256386: Completed NA study, sponsored by Kaiser Permanente.

NCT00256386 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 800 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00256386, a NA study, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
800 participants
Enrollment target

Study Summary

Errors and preventable adverse events associated with medication prescription and dispensing are common, and the difference between guideline recommendations and the actual frequency of laboratory monitoring is substantial. This study evaluates three interventions to improve laboratory monitoring at initiation of medication therapy: an electronic medical record reminder to the prescribing clinician (EMR), an automated voice message to the patient (AVM), and a pharmacy team outreach (Pharmacy) compared to usual care (UC).

Interventions

  • DEVICE Electronic Medical Record (EMR) to clinician's in-basket
  • DEVICE Automated Voice Message (AVM) reminder to patient's phone
  • PROCEDURE Pharmacy Team phone call-letter followup

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2004-01
Est. Completion 2005-03
Phase NA
Kaiser Permanente

294 total trials

What the finished NCT00256386 record still lists

NCT00256386 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).

The record links to 0 conditions, and to 3 interventions - of which Electronic Medical Record (EMR) to clinician's in-basket is the first listed.

NCT00256386 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00256386 about?

NCT00256386 is a clinical study titled "LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring". Errors and preventable adverse events associated with medication prescription and dispensing are common, and the difference between guideline recommendations and the actual frequency of laboratory monitoring is substantial. This study evaluates three interventions to improve laboratory monitoring at...

What is the current status of trial NCT00256386?

This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2004-01. Estimated completion is 2005-03.

What interventions are being tested in trial NCT00256386?

The interventions under investigation include: Electronic Medical Record (EMR) to clinician's in-basket (DEVICE), Automated Voice Message (AVM) reminder to patient's phone (DEVICE), Pharmacy Team phone call-letter followup (PROCEDURE).

Who is sponsoring clinical trial NCT00256386?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00256386's enrollment target sits among peer trials

800 135th of 2000 higher than 1,861 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00256386, the US trial registry maintained by the National Library of Medicine. NCT00256386 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.